Drug plans drop as Trump official targets PBMs ahead of speech

CVS HEALTH'S stock dipped Monday after a Trump official said that PBMs role in the health care industry was hurting patients. / BLOOMBERG FILE PHOTO/MICHAEL NAGLE
CVS HEALTH'S stock dipped Monday after a Trump official said that PBM operators' role in the health care industry was hurting patients. / BLOOMBERG FILE PHOTO/MICHAEL NAGLE
NEW YORK - Shares of CVS Health Corp. and Express Scripts Holding Co. slipped Monday after one of the Trump administration’s top health-care officials said the companies’ roles as intermediaries between drugmakers and health plans was hurting patients. Known as pharmacy-benefit managers, or PBMs, the plans negotiate with drugmakers to put their products on lists of…

Want More Free?

To access 2 more articles, please log in or register for free.

Registered users get access to a limited number of free articles every month.

Register Now

Already registered? Login to access more free articles.

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -